Mhealth Application for anTicoagulation Care in Atrial Fibrillation (MATCh AFib)
Atrial Fibrillation, Anticoagulants; Circulating, Hemorrhagic Disorder
About this trial
This is an interventional treatment trial for Atrial Fibrillation focused on measuring Mobile Health
Eligibility Criteria
Inclusion Criteria:
- Adults >=18 years
- Diagnostic of atrial fibrillation
- Indication of oral anticoagulation by their physician, based on risk scores
- Ability to speak, hear and understand Portuguese
- Able to receive and read text messages through a cell phone
Exclusion Criteria:
Physical impairments that prevent completion of the intervention, cognitive impairments that jeopardize informed consent and/or intervention comprehension and not fluent in Portuguese.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
MATCh AFib
Standard Care
Participants assigned to the intervention group will have the support of the MATCh AFib application during the consultations with their physician and receive individual text messaging targeting knowledge about atrial fibrillation, medication adherence and monitoring during months 1-3.
Participants assigned to the control group will complete measures at each time point and maintain care as usual (i.e., medical treatment, INR monitoring and consultations with their physician without mHealth support)